Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, Large B-Cell, Diffuse
×
Drug Therapy
×
Clear all
Filters
3
NCT03570892
2026-01-06
BELINDA
Novartis
Phase 3
Active not recruiting
331 enrolled
10 charts